Koalas vaccinated against Koala retrovirus respond by producing increased levels of interferon-gamma

被引:3
|
作者
Olagoke, Olusola [1 ]
Quigley, Bonnie L. [1 ]
Timms, Peter [1 ]
机构
[1] Univ Sunshine Coast, Genecol Res Ctr, Sunshine Coast, Qld, Australia
基金
澳大利亚研究理事会;
关键词
Koala retrovirus; Vaccination; Immune response; mRNA; NanoString;
D O I
10.1186/s12985-020-01442-7
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Koala retrovirus (KoRV) is believed to be in an active state of endogenization into the koala genome. KoRV is present as both an endogenous and exogenous infection in all koalas in northern Australia. KoRV has been linked to koala pathologies including neoplasia and increased susceptibility to Chlamydia. A KoRV vaccine recently trialled in 10 northern koalas improved antibody response and reduced viral load. This communication reports the expression of key immune genes underlining the innate and adaptive immune response to vaccination in these northern koalas. The results showed that prior to vaccination, IL-8 was expressed at the highest levels, with at least 200-fold greater expression compared to other cytokines, while CD8 mRNA expression was significantly higher than CD4 mRNA expression level. Interferon-gamma was up-regulated at both 4- and 8-weeks post-vaccination while IL-8 was down-regulated at 8-weeks post-vaccination.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] POLYCLONAL AND MONOCLONAL-ANTIBODIES AGAINST HUMAN INTERFERON-GAMMA
    STEFANOS, S
    WIETZERBIN, J
    CATINOT, L
    FALCOFF, R
    ANNALES DE VIROLOGIE, 1984, 135 (03): : 303 - 304
  • [32] Development and applications of a monoclonal antibody against caprine interferon-gamma
    Ma, Wen-Tao
    Liu, Qi
    Ning, Meng-Xia
    Qi, Yu-Xu
    Rehman, Saad
    Chen, De-Kun
    BMC BIOTECHNOLOGY, 2019, 19 (01)
  • [33] CDR MIMICRY WITH ANTIBODIES AGAINST THE EXTRACELLULAR INTERFERON-GAMMA RECEPTOR
    ROBINSON, JA
    BIRCH, A
    BRIDGES, A
    RUEGG, N
    WILLIAMS, G
    AGUET, M
    GAROTTA, G
    HUBER, W
    SCHLATTER, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 196 - 196
  • [34] EFFECT OF RECOMBINANT HUMAN INTERFERON-GAMMA AGAINST HUMAN CYTOMEGALOVIRUS
    YAMAMOTO, N
    SHIMOKATA, K
    MAENO, K
    NISHIYAMA, Y
    ARCHIVES OF VIROLOGY, 1987, 94 (3-4) : 323 - 329
  • [35] Development and applications of a monoclonal antibody against caprine interferon-gamma
    Wen-Tao Ma
    Qi Liu
    Meng-Xia Ning
    Yu-Xu Qi
    Saad Rehman
    De-Kun Chen
    BMC Biotechnology, 19
  • [36] SERUM INTERFERON-GAMMA LEVELS IN AUTOIMMUNE THYROID-DISEASE
    MATSUBAYASHI, S
    KASUGA, Y
    SAKATSUME, Y
    AKASU, F
    VOLPE, R
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1990, 13 (05): : 271 - 274
  • [37] Soluble interferon-gamma receptor (SIFN-gamma R) and interferon-gamma (IFN-gamma) levels in hematology patients undergoing bone marrow transplantation (BMT).
    Toren, A
    Barak, V
    Novick, D
    Nagle, A
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 128 - 128
  • [38] Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein
    O Olagoke
    D Miller
    F Hemmatzadeh
    T Stephenson
    J Fabijan
    P Hutt
    S Finch
    N Speight
    P Timms
    npj Vaccines, 3
  • [39] Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein
    Olagoke, O.
    Miller, D.
    Hemmatzadeh, F.
    Stephenson, T.
    Fabijan, J.
    Hutt, P.
    Finch, S.
    Speight, N.
    Timms, P.
    NPJ VACCINES, 2018, 3
  • [40] Adults with Mycobacterium tuberculosis infection and pre-diabetes have increased levels of QuantiFERON interferon-gamma responses
    Magee, Matthew J.
    Trost, Susanna L.
    Salindri, Argita D.
    Amere, Genet
    Day, Cheryl L.
    Gandhi, Neel R.
    TUBERCULOSIS, 2020, 122